Crestor and Excessive granulation tissue - a phase IV clinical study of FDA data

Summary:

Excessive granulation tissue is reported as a side effect among people who take Crestor (rosuvastatin calcium), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Excessive granulation tissue when taking Crestor. It is created by eHealthMe based on reports of 143,349 people who have side effects when taking Crestor from the FDA, and is updated regularly.

What is Crestor?

Crestor has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 149,763 Crestor users. Check the latest studies of Crestor.

What is Excessive granulation tissue?

Excessive granulation tissue (excessive collagen-rich tissue which forms at the site of an injury) is found to be associated with 388 drugs and 286 conditions by eHealthMe. Check the latest studies of Excessive granulation tissue.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

143,349 people reported to have side effects when taking Crestor.
Among them, 64 people (0.04%) have Excessive granulation tissue.

Could Crestor cause Excessive granulation tissue?

Among these 64 people:

How long have people been on Crestor when they have Excessive granulation tissue? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Excessive granulation tissue when taking Crestor? *

  • female: 80.95 %
  • male: 19.05 %

What is the age of people who have Excessive granulation tissue when taking Crestor? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 2.56 %
  • 30-39: 2.56 %
  • 40-49: 0.0 %
  • 50-59: 89.74 %
  • 60+: 5.13 %

What are other drugs people take besides Crestor? *

  1. Zometa: 53 people, 82.81%
  2. Aredia: 52 people, 81.25%
  3. Furosemide: 41 people, 64.06%
  4. Claritin: 33 people, 51.56%
  5. Warfarin Sodium: 32 people, 50.00%
  6. Xanax: 30 people, 46.88%
  7. Lasix: 29 people, 45.31%
  8. Gabapentin: 29 people, 45.31%
  9. Premarin: 28 people, 43.75%
  10. Zestril: 28 people, 43.75%

What are other side effects people have besides Excessive granulation tissue? *

  1. Pain: 53 people, 82.81%
  2. Primary Sequestrum (piece of dead bone that has become separated during the process of necrosis from normal/sound bone): 52 people, 81.25%
  3. Pleural Effusion (water on the lungs): 50 people, 78.12%
  4. Stress And Anxiety: 49 people, 76.56%
  5. Toothaches (tooth pain): 48 people, 75.00%
  6. Visual Impairment: 45 people, 70.31%
  7. Tooth Abscess (pus formation in tooth): 45 people, 70.31%
  8. Bone Disorder: 44 people, 68.75%
  9. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 44 people, 68.75%
  10. Osteonecrosis Of Jaw (death of bone of jaw): 44 people, 68.75%

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 29 people, 45.31%
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints): 22 people, 34.38%
  3. Nausea (feeling of having an urge to vomit): 22 people, 34.38%
  4. Depression: 22 people, 34.38%
  5. Sleep Disorder: 22 people, 34.38%
  6. Muscle Spasms (muscle contraction): 22 people, 34.38%
  7. Hypercalcaemia (elevated calcium (ca+) level in the blood): 21 people, 32.81%
  8. High Blood Pressure: 8 people, 12.50%
  9. Parkinson's Disease: 2 people, 3.12%
  10. Metastases To Bone (cancer spreads to bone): 2 people, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Crestor and have Excessive granulation tissue?

- Check whether Excessive granulation tissue is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Crestor:

Excessive granulation tissue treatments and more:

How severe was Excessive granulation tissue and when was it recovered:

Expand to all the drugs that have ingredients of rosuvastatin calcium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Crestor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Excessive granulation tissue:

Browse all the conditions that are associated with Excessive granulation tissue:


How the study uses the data?

The study uses data from the FDA. It is based on rosuvastatin calcium (the active ingredients of Crestor) and Crestor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: